Moderna Vaccine mRNA-1345 Observational Respiratory Syncytial Virus (RSV) Study

NCT05572658 · clinicaltrials.gov ↗

COMPLETED

Status

10994

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Syncytial Virus

Interventions

BIOLOGICAL: mRNA-1345
BIOLOGICAL: Placebo

Sponsor

ModernaTX, Inc.